JASN
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
Keyword(s):
Year:  Vol:  Page: 


Receive this page by email each issue: [Sign up for eTOCs]

  Contents: Volume 16, Supplement 1 Issue 3, March 2005   [Index by Author] 
      PROCEEDINGS OF THE THIRD GENOA MEETING ON HYPERTENSION, DIABETES, AND RENAL DISEASES
      Articles
Other Issues:
Find articles in this issue containing these words:
[Search ALL Issues]


To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.

PROCEEDINGS OF THE THIRD GENOA MEETING ON HYPERTENSION, DIABETES, AND RENAL DISEASES:

Introduction
Giacomo Deferrari and Roberto Pontremoli
J Am Soc Nephrol 16: S1. [Full Text] [PDF]  

Articles:

Stem Cells and Cardiovascular and Renal Disease: Today and Tomorrow
Volker Schächinger and Andreas M. Zeiher
J Am Soc Nephrol 16: S2-S6. [Abstract] [Full Text] [PDF]  

Oral Antihyperglycemic Agents and Renal Disease: New Agents, New Concepts
Jean-François Yale
J Am Soc Nephrol 16: S7-S10. [Abstract] [Full Text] [PDF]  

Are 3-Hydroxy-3-Methylglutaryl-CoA Reductase Inhibitors Renoprotective?
Vito M. Campese, Mitra K. Nadim, and Murray Epstein
J Am Soc Nephrol 16: S11-S17. [Abstract] [Full Text] [PDF]  

Antihypertensive Treatment and Multifactorial Approach for Renal Protection in Diabetes
Paola Fioretto and Anna Solini
J Am Soc Nephrol 16: S18-S21. [Abstract] [Full Text] [PDF]  

Treatment of High-Risk Patients with Diabetes: Motivation and Teaching Intervention: A Randomized, Prospective 8-Year Follow-Up Study
Rita Rachmani, Inna Slavacheski, Maya Berla, Ronni Frommer-Shapira, and Mordchai Ravid
J Am Soc Nephrol 16: S22-S26. [Abstract] [Full Text] [PDF]  

Nephron Number and Renal Risk in Hypertension and Diabetes
Marie-Luise Gro{beta}, Kerstin Amann, and Eberhard Ritz
J Am Soc Nephrol 16: S27-S29. [Abstract] [Full Text] [PDF]  

Pathogenetic Mechanisms of Diabetic Nephropathy
Francesco P. Schena and Loreto Gesualdo
J Am Soc Nephrol 16: S30-S33. [Abstract] [Full Text] [PDF]  

Dual Blockade of the Renin-Angiotensin System: The Ultimate Treatment for Renal Protection?
Igor Codreanu, Norberto Perico, and Giuseppe Remuzzi
J Am Soc Nephrol 16: S34-S38. [Abstract] [Full Text] [PDF]  

Role of Microalbuminuria in the Assessment of Cardiovascular Risk in Essential Hypertension
Roberto Pontremoli, Giovanna Leoncini, Francesca Viazzi, Denise Parodi, Valentina Vaccaro, Valeria Falqui, Angelica Parodi, Simone Vettoretti, Elena Ratto, and Giacomo Deferrari
J Am Soc Nephrol 16: S39-S41. [Abstract] [Full Text] [PDF]  

Targeting Albumin Excretion Rate in the Treatment of the Hypertensive Diabetic Patient with Renal Disease
Michael J. Krimholtz, Janaka Karalliedde, Stephen Thomas, Rudy Bilous, and Giancarlo Viberti
J Am Soc Nephrol 16: S42-S47. [Abstract] [Full Text] [PDF]  

Prevention and Treatment of Diabetic Nephropathy: The Program for Irbesartan Mortality and Morbidity Evaluation
Maura Ravera, Elena Ratto, Simone Vettoretti, Denise Parodi, and Giacomo Deferrari
J Am Soc Nephrol 16: S48-S52. [Abstract] [Full Text] [PDF]  

Individual Titration for Maximal Blockade of the Renin-Angiotensin System in Proteinuric Patients: A Feasible Strategy?
Liffert Vogt, Gerjan Navis, and Dick de Zeeuw
J Am Soc Nephrol 16: S53-S57. [Abstract] [Full Text] [PDF]  

Angiotensin-Converting Enzyme Inhibition and Renal Protection in Nondiabetic Patients: The Data of the Meta-Analyses
Carlos Chiurchiu, Giuseppe Remuzzi, and Piero Ruggenenti
J Am Soc Nephrol 16: S58-S63. [Abstract] [Full Text] [PDF]  

Calcium Channel Blockers and Renal Protection: Insights from the Latest Clinical Trials
Julián Segura, José A. García-Donaire, and Luis M. Ruilope
J Am Soc Nephrol 16: S64-S66. [Abstract] [Full Text] [PDF]  

Epoetin-Induced Autoimmune Pure Red Cell Aplasia
Nicole Casadevall, Kai-Uwe Eckardt, and Jérôme Rossert
J Am Soc Nephrol 16: S67-S69. [Abstract] [Full Text] [PDF]  

Should a Diuretic Always Be the First Choice in Patients with Essential Hypertension? The Case for No
Alberto Morganti
J Am Soc Nephrol 16: S70-S73. [Abstract] [Full Text] [PDF]  

Joint National Committee VII and European Society of Hypertension/European Society of Cardiology Guidelines for Evaluating and Treating Hypertension: A Two-Way Road?
Giuseppe Mancia and Guido Grassi
J Am Soc Nephrol 16: S74-S77. [Abstract] [Full Text] [PDF]  

Acute-Phase Markers of Inflammation and Glomerular Structure in Patients with Type 2 Diabetes
Michele Dalla Vestra, Michele Mussap, Pietro Gallina, Marino Bruseghin, Anna Maria Cernigoi, Alois Saller, Mario Plebani, and Paola Fioretto
J Am Soc Nephrol 16: S78-S82. [Abstract] [Full Text] [PDF]  

Inflammation Markers, Adhesion Molecules, and All-Cause and Cardiovascular Mortality in Patients with ESRD: Searching for the Best Risk Marker by Multivariate Modeling
Giovanni Tripepi, Francesca Mallamaci, and Carmine Zoccali
J Am Soc Nephrol 16: S83-S88. [Abstract] [Full Text] [PDF]  

Impact of Target Organ Damage Assessment in the Evaluation of Global Risk in Patients with Essential Hypertension
Francesca Viazzi, Giovanna Leoncini, Denise Parodi, Elena Ratto, Simone Vettoretti, Valentina Vaccaro, Angelica Parodi, Valeria Falqui, Cinzia Tomolillo, Giacomo Deferrari, and Roberto Pontremoli
J Am Soc Nephrol 16: S89-S91. [Abstract] [Full Text] [PDF]  

To see an article, click its [Full Text] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2005 by the American Society of Nephrology.